SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is trending amidst mixed sentiment, with some traders anticipating a pump while others remain skeptical, citing past pump and dumps. Discussions revolve around its potential correlation with Bitcoin and Ethereum's movements, and the impact of a recent governance vote. Some community members suggest comparing COMP to AAVE.

Compass, Inc. engages in the provision of an online real estate platform. Its platform provides an integrated suite of software for customer relationship management, marketing, client service, operations and other critical functionality, as well as brokerage services and adjacent services. The company was founded by Ori Allon and Robert Reffkin in 2012 and is headquartered in New York, NY.

Compass Inc - Ordinary Shares - Class A

Compass Inc is trending as investors discuss its growth potential amid mixed real estate market signals and anticipation surrounding future Fed rate decisions. Community members are weighing its prospects against competitors like Opendoor and Zillow, analyzing financial health, and debating if the company represents a value opportunity or if it's overvalued.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant is trending as the community discusses its potential role in real-world asset tokenization and interoperability between blockchains, particularly highlighting its involvement in projects like the digital euro pilot and tokenized sterling deposits. Bullish sentiment is fueled by increasing institutional adoption and the limited supply of QNT, with some traders eyeing a breakout above key resistance levels. The recent buzz is around Quant's potential to revolutionize multi-chain finance and its expanding network.

Codatta

XNY (Codatta) is trending as the community discusses its potential for a breakout and recovery, particularly in relation to movements in BTC. Recent exchange listings have increased accessibility, and the project's focus on powering AI's data future is also a key talking point, with some highlighting its strong performance even amidst market dips.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as the 21Shares spot XRP ETF launched on December 1st, sparking excitement among the XRP community. Investors are actively discussing the ETF's potential to drive broader adoption and institutional investment, while some debate XRP's long-term utility and real-world applications.

Next Technology Holding, Inc. engages in the provision of software development services to the customers and bitcoin acquisition. The company was founded on March 28, 2019 and is headquartered in Shenzhen, China.

Next Technology Holding Inc.

NXTT is trending due to a significant price surge and high trading volume, sparking discussions about its connection to Bitcoin holdings and potential for a short squeeze. The community is debating the company's value relative to its Bitcoin assets and speculating on upcoming news or SEC filings as catalysts. Some traders are expressing skepticism, citing past reverse splits and potential dilution.

HP Inc. is an information technology company, which engages in the provision of personal computing and other access devices, imaging and printing products, and related technologies, solutions, and services. It operates through the following segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktop and notebook personal computers, workstations, thin clients, commercial tablets and mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services for the commercial and consumer markets. The Printing segment provides consumer and commercial printer hardware, supplies, solutions and services, and scanning devices. The Corporate Investments segment includes HP Labs and certain business incubation projects. The company was founded by William R. Hewlett and David Packard in 1939 and is headquartered in Palo Alto, CA.

HP Inc

HPQ is trending due to a mix of factors including recent earnings, analyst rating adjustments, and discussions around a potential AI-driven transformation and workforce restructuring. While some community members are focused on dividend increases and options trading, others are weighing in on revenue outlook and the company's strategy in relation to AI and market competition. Discussions also involve HPQ's settlement with investors and potential manufacturing shifts.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax ($ABVX) is trending following positive Phase 3 trial results for its ulcerative colitis treatment, with the stock experiencing a significant surge. Community discussions revolve around the potential for a buyout and comparisons to similar situations with other biotech stocks. The focus is now on the drug's potential in a large market, and if it can secure broad adoption.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure ($QURE) is trending amid discussions about its Huntington's disease treatment and potential FDA actions, with community members debating the likelihood of approval and speculating on potential buyouts. The community is focused on the company's regulatory path and the impact of FDA decisions on its future. Broader discussions include the role of leadership at the FDA and the potential for political influence in drug approvals.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is trending on strong Auvelity sales and potential FDA acceptance of AXS-05 for Alzheimer's agitation, with the community closely monitoring prescription numbers and upcoming catalysts. Investors are also discussing the possibility of a buyout, given the company's attractive pipeline and strategic positioning in the CNS space. Some are concerned with high marketing expenses and the lack of a partnership deal.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GCAN So you like the low float  Maybe he can do another 1,500 for 1 Reverse split like last month.  This scam would look great with only 600 shares OS, right?

gregc4

$GCAN All we can hope for now is news on the Reverse Merger comes soon. With the new 900K OS, this could be something very special. Hope Aitan does the right thing here and makes this a multi-dollar stock. This is now ripe for something good. Fingers crossed.

StockTwits Web

Greater Cannabis Company Inc

 So you like the low float  Maybe he can do another 1,500 for 1 Reverse split like last month.  This scam would look great with only 600 shares OS, right?